Jiawei Zhou
机构：Hangzhou Normal University, Chinese Anti-Cancer Association · ORCID：0009-0007-8501-8902
发表论文 84 篇 · 总被引 1592 次 · h-index 16
代表论文
- Novel Bifunctional Conjugates Targeting PD-L1/PARP7 as Dual Immunotherapy for Potential Cancer Treatment (2024 · Journal of Medicinal Chemistry · 被引 19)
- A Balanced CMOS Compatible Ternary Memristor-NMOS Logic Family and Its Application (2024 · IEEE Transactions on Circuits and Systems I Regular Papers · 被引 18)
- Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213) (2024 · Journal of Cachexia Sarcopenia and Muscle · 被引 15)
- Novel ATR/PARP1 Dual Inhibitors Demonstrate Synergistic Antitumor Efficacy in Triple‐Negative Breast Cancer Models (2025 · Advanced Science · 被引 12)
- Ingenol ameliorates silicosis via targeting the PTGS2/PI3K/AKT signaling axis: Implications for therapeutic intervention (2025 · Cellular Signalling · 被引 10)
- Artesunate-binding FABP5 promotes apoptosis in lung cancer cells via the PPARγ-SCD pathway (2024 · International Immunopharmacology · 被引 10)